Evidence map›Paper›PMID 35344616›Full record

ArticleHuman mutation2022

Phenotypic and mutational spectrum of ROR2-related Robinow syndrome.

Ariadne R Lima, Barbara M Ferreira, Chaofan Zhang, Angad Jolly, Haowei Du, Janson J White, Moez Dawood, Tulio C Lins, Marcela A Chiabai, Ellen van Beusekom and 39 more

Open access · bronzeAbstract read
In one paragraph

Article in Human mutation, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Robinow syndrome DVL1 variants disrupt morphogenesis and appendage formation in a Drosophila disease model.Developmental dynamics : an official publication of the American Association of Anatomists · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

49 authors at 20 institutions in 8 countries.

Ariadne R LimaPrograma de Pós-Graduação em Ciências da Saúde, Universidade de Brasília, Brasília, DF, Brasil.
Barbara M FerreiraPrograma de Pós-Graduação em Ciências Médicas, Universidade de Brasília, Brasília, DF, Brasil.
Chaofan ZhangDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, USA.
Angad JollyDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, USA.
Haowei DuDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, USA.ORCID 0000-0001-9052-1587
Janson J WhiteDepartment of Pediatrics, University of Washington, Seattle, Washington, USA.
Moez DawoodDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, USA.
Tulio C LinsPrograma de Pós-graduação em Ciências Genômicas e Biotecnologia, Universidade Católica de Brasília, Brasília, DF, Brasil.
Marcela A ChiabaiPrograma de Pós-graduação em Ciências Genômicas e Biotecnologia, Universidade Católica de Brasília, Brasília, DF, Brasil.
Ellen van BeusekomRadboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.
Mara S CordobaFaculdade de Medicina, Universidade de Brasília, Brasília, DF, Brasil.
Erica C C Caldas RosaPrograma de Pós-Graduação em Ciências da Saúde, Universidade de Brasília, Brasília, DF, Brasil.
Hulya KayseriliMedical Genetics Department, School of Medicine (KUSoM), Koç University, Istanbul, Turkey.
Virginia KimonisDivision of Genetics and Genomic Medicine, Department of Pediatrics, University of California-Irvine, Irvine, California, USA.
Erica WuObstetrics and Gynecology, Stanford University, Stanford, California, USA.
Cecilia MelladoUnidad de Genética, División de Pediatría, Pontificia Universidad Católica de Chile, Santiago, Chile.
Vineet AggarwalDepartment of Orthopedics, Indira Gandhi Medical College, Snowdon, India.
Antonio Richieri-CostaHospital de Reabilitação de Anomalias Craniofaciais, Bauru, Brasil.
Décio BrunoniUniversidade Presbiteriana Mackenzie-UPM, São Paulo, Brasil.
Talyta M CanóPrograma de Pós-Graduação em Ciências Médicas, Universidade de Brasília, Brasília, DF, Brasil.
Alexander A L JorgeLaboratório de Endocrinologia Celular e Molecular LIM25, Disciplina de Endocrinologia da Faculdade de Medicina da Universidade de São Paulo, Unidade de Endocrinologia Genética, São Paulo, Brasil.
Chong A KimUnidade de Genética, Instituto da Criança-Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brasil.
Rachel HonjoUnidade de Genética, Instituto da Criança-Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brasil.
Débora R BertolaUnidade de Genética, Instituto da Criança-Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brasil.
Raissa M Dandalo-GirardiPrograma de Mestrado Profissional em Aconselhamento Genético e Genômica Humana, Instituto de Biociências, Universidade de São Paulo, São Paulo, Brasil.
Yavuz BayramDepartment of Pathology and Laboratory Medicine, Division of Genomic Diagnostics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Alper GezdiriciDepartment of Medical Genetics, Basaksehir Cam and Sakura City Hospital, Istanbul, Turkey.
Elif Yilmaz-GulecSchool of Medicine, Istanbul Medeniyet University, Istanbul, Turkey.
Evren GumusMedical Genetics Department, Medicine Faculty, Mugla Sitki Kocman University, Mugla, Turkey.
Gülay C YilmazMedical Genetics Department, Medicine Faculty, Mugla Sitki Kocman University, Mugla, Turkey.
Nobuhiko OkamotoDepartment of Medical Genetics, Osaka Women's and Children's Hospital, Osaka, Japan.ORCID 0000-0001-5415-656X
Hirofumi OhashiSaitama Children's Medical Center, Division of Medical Genetics, Saitama, Japan.
Zeynep Coban-AkdemirDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, USA.
Tadahiro MitaniDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, USA.
Shalini N JhangianiHuman Genome Sequencing Center, Baylor College of Medicine, Houston, Texas, USA.
Donna M MuznyHuman Genome Sequencing Center, Baylor College of Medicine, Houston, Texas, USA.
Neysa A P RegattieriFaculdade de Medicina, Universidade de Brasília, Brasília, DF, Brasil.
Robert PoguePrograma de Pós-graduação em Ciências Genômicas e Biotecnologia, Universidade Católica de Brasília, Brasília, DF, Brasil.ORCID 0000-0002-8789-3512
Rinaldo W PereiraPrograma de Pós-graduação em Ciências Genômicas e Biotecnologia, Universidade Católica de Brasília, Brasília, DF, Brasil.
Paulo A OttoDepartamento de Genética e Biologia Evolutiva, Instituto de Biociências, Universidade de São Paulo, São Paulo, Brasil.
Richard A GibbsHuman Genome Sequencing Center, Baylor College of Medicine, Houston, Texas, USA.
Bassam R AliDepartment of Genetics and Genomics, College of Medicine and Health Sciences, United Arab Emirates University, Al-Ain, United Arab Emirates.
Hans van BokhovenRadboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.
Han G BrunnerRadboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.
V Reid SuttonDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, USA.
James R LupskiDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, USA.ORCID 0000-0001-9907-9246
Angela M Vianna-MorganteDepartamento de Genética e Biologia Evolutiva, Instituto de Biociências, Universidade de São Paulo, São Paulo, Brasil.
Claudia M B CarvalhoDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, USA.
Juliana F MazzeuPrograma de Pós-Graduação em Ciências da Saúde, Universidade de Brasília, Brasília, DF, Brasil.ORCID 0000-0002-6161-0510
Baylor College of Medicine · USRadboud University Nijmegen · NLUniversidade de Brasília · BRUniversidade de São Paulo · BRHospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo · BRMuğla University · TRUniversidade Católica de Brasília · BRChildren's Hospital of Philadelphia · USIndira Gandhi Medical College · INIstanbul Medeniyet University · TRIstanbul Metropolitan Municipality · TRKoç University · TROsaka Women's and Children's Hospital · JPPacific Northwest Diabetes Research Institute · USPontificia Universidad Católica de Chile · CLSaitama Children's Medical Center · JPStanford University · USUnited Arab Emirates University · AEUniversidade Presbiteriana Mackenzie · BRUniversity of California, Irvine · US

Funding

Baylor-Johns Hopkins Center for Mendelian GeneticsUM1HG006542 · NHGRI · JOHNS HOPKINS UNIVERSITY · PI VALLE, DAVID · 2016 to 2020
$14.5M
STRUCTURAL VARIATION IN NEUROLOGICAL DISEASER35NS105078 · NINDS · BAYLOR COLLEGE OF MEDICINE · PI LUPSKI, JAMES R. · 2018 to 2025
$6.0M
Uncovering inversion formation in the human genome and its impact to disease.R01GM132589 · NIGMS · PACIFIC NORTHWEST RESEARCH INSTITUTE · PI FONSECA, CLAUDIA CARVALHO · 2020 to 2024
$3.5M
Discovery and functional characterization of genic variants leading to Robinow syndrome and related skeletal dysplasias.R03HD092569 · NICHD · BAYLOR COLLEGE OF MEDICINE · PI FONSECA, CLAUDIA CARVALHO, SUTTON, VERNON R · 2018 to 2019
$238k
NHGRI NIH HHS UM1 HG006542NHGRI NIH HHS UM1HG006542NICHD NIH HHS R03 HD092569NIGMS NIH HHS R01 GM132589NINDS NIH HHS R35 NS105078
6 · The paper itself

Abstract

Robinow syndrome is characterized by a triad of craniofacial dysmorphisms, disproportionate-limb short stature, and genital hypoplasia. A significant degree of phenotypic variability seems to correlate with different genes/loci. Disturbances of the noncanonical WNT-pathway have been identified as the main cause of the syndrome. Biallelic variants in ROR2 cause an autosomal recessive form of the syndrome with distinctive skeletal findings. Twenty-two patients with a clinical diagnosis of autosomal recessive Robinow syndrome were screened for variants in ROR2 using multiple molecular approaches. We identified 25 putatively pathogenic ROR2 variants, 16 novel, including single nucleotide variants and exonic deletions. Detailed phenotypic analyses revealed that all subjects presented with a prominent forehead, hypertelorism, short nose, abnormality of the nasal tip, brachydactyly, mesomelic limb shortening, short stature, and genital hypoplasia in male patients. A total of 19 clinical features were present in more than 75% of the subjects, thus pointing to an overall uniformity of the phenotype. Disease-causing variants in ROR2, contribute to a clinically recognizable autosomal recessive trait phenotype with multiple skeletal defects. A comprehensive quantitative clinical evaluation of this cohort delineated the phenotypic spectrum of ROR2-related Robinow syndrome. The identification of exonic deletion variant alleles further supports the contention of a loss-of-function mechanism in the etiology of the syndrome.

Indexed as

Craniofacial AbnormalitiesDwarfismLimb Deformities, CongenitalReceptor Tyrosine Kinase-like Orphan ReceptorsUrogenital AbnormalitiesGenes, RecessiveHumansMalePhenotypeReceptor Tyrosine Kinase-like Orphan ReceptorsROR2 protein, humanchromosome microarray analysiscraniofacial morphologyexonic deletionHPO termsnext-generation sequencingquantitative phenotyping cluster heatmapskeletal dysplasiaWNT pathway

Identifiers

PMID35344616
PMCPMC9177636
OpenAlexW4220895021

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.